The Revolutionary Impact of Monoclonal Antibody Therapy on the Management of Allergic Pruritus in Canines during 2025
One of the most significant breakthroughs in the 2025 veterinary field is the widespread adoption of monoclonal antibody therapy for the treatment of canine atopic dermatitis. Specifically, the use of lokivetmab has transformed the life of millions of dogs by targeting and neutralizing interleukin-31, a key cytokine responsible for sending itch signals to the brain. Unlike traditional chemical...
0 Comments 0 Shares 8 Views 0 Reviews